Serial soluble neurofilament heavy chain in plasma as a marker of brain injury after cardiac arrest

Critical Care

Volumn 16, Issue 2, 2012, Pages

  Rundgren, Malin ^a   Friberg, Hans ^a   Cronberg, Tobias ^b   Romner, Bertil ^c   Petzold, Axel ^d,e  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; NEUROFILAMENT HEAVY CHAIN PROTEIN; NEUROFILAMENT PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BRAIN INJURY; CEREBRAL PERFORMANCE CATEGORY SCALE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HEART ARREST; HUMAN; HYPOTHERMIA; MAJOR CLINICAL STUDY; MALE; NERVE DEGENERATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN PHOSPHORYLATION; RATING SCALE; AREA UNDER THE CURVE; BLOOD; INDUCED HYPOTHERMIA; MIDDLE AGED; NONPARAMETRIC TEST; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; TREATMENT OUTCOME;

AGED; AREA UNDER CURVE; BIOMARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART ARREST; HUMANS; HYPOTHERMIA, INDUCED; MALE; MIDDLE AGED; NEUROFILAMENT PROTEINS; PROGNOSIS; PROSPECTIVE STUDIES; ROC CURVE; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 84857989908     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc11244     Document Type: Article

References (32)

1. Nolan J, Neumar R, Adrie C, Aibiki M, Berg R, Böttinger B, Callaway C, Clark R, Geocadin R, Jauch E, Kern K, Laurent I, Longstreeth W, Merchant R, Morley P, Morrison L, Nadkarni V, Peberdy M, Rivers E, Rodriguez-Nunez A, Sellke F, Spaulding C, Sunde K, Hoek T. Post-cardiac arrest syndrome: epidemiology, pathophysiology, treatment, and prognostication: a Scientific Statement from the International Liaison Committee on Resuscitation; the American Heart Association Emergency Cardiovascular Care Committee; the Council on Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Perioperative, and Critical Care; the Council on Clinical Cardiology; the Council on Stroke (Part II). Int Emerg Nursing 2010, 18:8-28.
2. Laver S, Farrow C, Turner D, Nolan J. Mode of death after admission to an intensive care unit following cardiac arrest. Intensive Care Med 2004, 30:2126-2128. 10.1007/s00134-004-2425-z, 15365608.
3. Pulsinelli WA, Brierley JB, Plum F. Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann Neurol 1982, 11:491-498. 10.1002/ana.410110509, 7103425.
4. Edgren E, Hedstrand U, Kelsey S, Sutton-Tyrrell K, Safar P. Assessment of neurological prognosis in comatose survivors of cardiac arrest. BRCT I Study Group. Lancet 1994, 343:1055-1059. 10.1016/S0140-6736(94)90179-1, 7909098.
5. Zandbergen E, Hijdra A, Koelman J, Hart A, Vos P, Verbeek M, de Haan R, . PROPAC Study Group Prediction of poor outcome within the first 3 days of postanoxic coma. Neurology 2006, 66:62-68. PROPAC Study Group.
6. Wijdicks EF, Hijdra A, Young G, Bassetti CL, Wiebe S, . Quality Standards Subcommittee of the American Academy of Neurology Practice parameter: prediction of outcome in comatose survivors after cardiopulmonary resuscitation (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2006, 67:203-210. 10.1212/01.wnl.0000227183.21314.cd, 16864809, Quality Standards Subcommittee of the American Academy of Neurology.
7. Tortorici M, Kochanek P, Poloyac S. Effects of hypothermia on drug disposition, metabolism, and response: A focus of hypothermia -mediated alterations on the cytochrome P450 enzyme system. Crit Care Med 2007, 35:2196-2204. 10.1097/01.CCM.0000281517.97507.6E, 17855837.
8. Rossetti AO, Oddo M, Logroscino G, Kaplan PW. Prognostication after cardiac arrest and hypothermia: a prospective study. Ann Neurol 2010, 67:301-307.
9. Thenayan EA, Savard M, Sharpe M, Norton L, Young B. Predictors of poor neurologic outcome after induced mild hypothermia following cardiac arrest. Neurology 2008, 71:1535-1537. 10.1212/01.wnl.0000334205.81148.31, 18981375.
10. Cronberg T, Rundgren M, Westhall E, Englund E, Siemund R, Rosén I, Widner H, Friberg H. Neuron-specific enolase correlates with other prognostic markers after cardiac arrest. Neurology 2011, 77:623-630. 10.1212/WNL.0b013e31822a276d, 21775743.
11. Kaneko T, Kasaoka S, Miyauchi T, Fujita M, Oda Y, Tsuruta R, Maekawa T. Serum glial fibrillary acidic protein as a predictive biomarker of neurological outcome after cardiac arrest. Resuscitation 2009, 80:790-794. 10.1016/j.resuscitation.2009.04.003, 19411130.
12. Rundgren M, Karlsson T, Nielsen N, Cronberg T, Johnsson P, Friberg H. Neuron specific enolase and S-100B as predictors of outcome after cardiac arrest and induced hypothermia. Resuscitation 2009, 80:784-789. 10.1016/j.resuscitation.2009.03.025, 19467754.
13. Fugate JE, Wijdicks EF, Mandrekar J, Claassen D, Manno E, White R, Bell M, Rabinstein A. Predictors of neurologic outcome in hypothermia after cardiac arrest. Ann Neurol 2010, 68:907-914. 10.1002/ana.22133, 21061401.
14. Stern P, Bartos V, Uhrova J, Bezdickova D, Vanickova Z, Tichy V, Pelinkova K, Prusa R, Zima T. Performance characteristics of seven neuron-specific enolase assays. Tumour Biol 2007, 28:84-92. 10.1159/000098441, 17259755.
15. Johnsson PBS, Luhrs C, Malmkvist G, Alling C, Solem JO, Stahl E. Neuron-specific enolase increases in plasma during and immediately after extracorporeal circulation. Ann Thorac Surg 2000, 69:750-754. 10.1016/S0003-4975(99)01393-4, 10750755.
16. Anderson R, Hansson L, Nilsson O, Liska J, Settergren G, Vaage J. Increase in serum S100A1-B and S100BB during cardiac surgery arises from extracerebral sources. Ann Thorac Surg 2001, 71:1512-1517. 10.1016/S0003-4975(01)02399-2, 11383792.
17. Undén J, Bellner J, Eneroth M, Alling C, Ingebrigtsen T, Romner B. Raised serum S100B levels after acute bone fractures without cerebral injury. J Trauma 2005, 58:59-61. 10.1097/01.TA.0000130613.35877.75, 15674151.
18. Petzold A. Neurofilament phosphoforma: Surrogate markters for axomal injury, degeneration and loss. J Neurol Sci 2005, 233:183-198. 10.1016/j.jns.2005.03.015, 15896809.
19. Jensen HA, Loukogeorgakis S, Yannopoulos F, Rimipiläinen E, Petzold A, Tuominen H, Lepola P, Macallister RJ, Deanfield JE, Mäkelä T, Alestalo K, Kiviluoma K, Anttila V, Tsang V, Juvonen T. Remote ischemic preconditioning protects the brain against injury after hypothermic circulatory arrest. Circulation 2011, 123:714-721. 10.1161/CIRCULATIONAHA.110.986497, 21300953.
20. Kuhle J, Leppert D, Petzold A, Regeniter A, Schindler C, Mehlin M, Anthony DC, Kappos L, Lindberg RL. Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosis. Neurology 2011, 76:1206-1213. 10.1212/WNL.0b013e31821432ff, 21346223.
21. Petzold A, Michel P, Stock M, Schluep M. Glial and axonal body fluid biomarkers are related to infarct volume, severity, and outcome. J Stroke Cerebrovasc Dis 2008, 17:196-203. 10.1016/j.jstrokecerebrovasdis.2008.02.002, 18589339.
22. Rosen H, Karlsson JE, Rosengren L. CSF levels of neurofilament is a valuable predictor of long-term outcome after cardiac arrest. J Neurol Sci 2004, 221:19-24. 10.1016/j.jns.2004.03.003, 15178208.
23. Sellner J, Patel A, Dassan P, Brown M, Petzold A. Hyperacute detection of neurofilament heavy chain in serum following stroke: a transient sign. Neurochem Res 2011, 36(12):2287-2291. 10.1007/s11064-011-0553-8, 21792676.
24. Sellner J, Petzold A, Sadikovic A, Esposito L, Weber M, Heider P, Eckstein H-H, Memmer B, Poppert H. The value of the serum neurofilament protein heavy chain as a biomarker for peri-operative brain injury after carotid endarterectomy. Neurochem Res 2009, 34:1969-1974. 10.1007/s11064-009-9976-x, 19430903.
25. Rundgren M, Rosen I, Friberg H. Amplitude-integrated EEG (aEEG) predicts outcome after cardiac arrest and induced hypothermia. Intensive Care Med 2006, 32:836-842. 10.1007/s00134-006-0178-6, 16715325.
26. Jennett B, Bond M. Assessment of outcome after severe brain damage. Lancet 1975, 1:480-484.
27. Petzold A, Keir G, Green AJ, Giovannoni G, Thompson EJ. A specific ELISA for measuring neurofilament heavy chain phosphoforms. J Immunol Methods 2003, 278:179-190. 10.1016/S0022-1759(03)00189-3, 12957406.
28. Petzold A, Verwey NA, van Uffelen K, Blankenstein MA, Teunissen C. Batch prepared protein standards for cerebrospinal fluid (CSF) biomarkers for neurodegeneration. J Neurosci Methods 2010, 193:296-299. 10.1016/j.jneumeth.2010.08.028, 20832428.
29. Eikelenboom MJ, Uitdehaag BMJ, Petzold A. Blood and CSF Biomarker Dynamics in Multiple Sclerosis: Implications for Data Interpretation. Mult Scler Int 2011, 2011:823176. 3195856, 22096644.
30. Petzold A, Tisdall MM, Girbes AR, Martinian L, Thom M, Kitchen N, Smith M. In vivo monitoring of neuronal loss in traumatic brain injury: a microdialysis study. Brain 2011, 134:464-483. 10.1093/brain/awq360, 3030768, 21278408.
31. Petzold A, Keir G, Kay A, Kerr M, Thompson EJ. Axonal damage and outcome in subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 2006, 77:753-759. 10.1136/jnnp.2005.085175, 2077447, 16705199.
32. Singh P, Yan J, Hull R, Read S, O'Sullivan J, Henderson RD, Rose S, Greer JM, McCombe PA. Levels of phosphorylated axonal neurofilament subunit H (pNfH) are increased in acute ischemic stroke. J Neurol Sci 2011, 304:117-121. 10.1016/j.jns.2011.01.025, 21349546.